76497-69-3 Usage
Uses
Used in Pharmaceutical Industry:
15,16-Dir-8(17),11-labdadien-13-one is used as a pharmaceutical agent for its potential anti-inflammatory properties, making it a candidate for the development of treatments targeting inflammation-related conditions.
Used in Oncology Research:
In the field of oncology, 15,16-Dir-8(17),11-labdadien-13-one is utilized as a subject of research for its anti-cancer properties, with potential applications in the discovery and development of novel cancer therapeutics.
Used in Neuroprotective Therapies:
15,16-Dir-8(17),11-labdadien-13-one is employed as a neuroprotective agent in research aimed at finding treatments for neurodegenerative diseases, given its potential to protect neurons and mitigate neuronal damage.
Used in Natural Products Chemistry:
As a complex natural product, 15,16-Dir-8(17),11-labdadien-13-one is used in chemical research to understand its structure-activity relationships, which can lead to the optimization of its medicinal properties and the creation of new compounds with improved efficacy.
Used in Medicinal Chemistry:
In medicinal chemistry, 15,16-Dir-8(17),11-labdadien-13-one serves as a lead compound for the design and synthesis of new pharmaceuticals, leveraging its biological activities to address various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 76497-69-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,4,9 and 7 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 76497-69:
(7*7)+(6*6)+(5*4)+(4*9)+(3*7)+(2*6)+(1*9)=183
183 % 10 = 3
So 76497-69-3 is a valid CAS Registry Number.
76497-69-3Relevant academic research and scientific papers
Photosensitized Oxygenation of Labda-8(17),12-diene, Labda-8(17),13-diene, and the Biformenes. Synthesis of Pumiloxide
Mohanraj, Subramaniam,Herz, Werner
, p. 1362 - 1366 (2007/10/02)
Reactions of the title compounds with singlet oxygen were studied.In labda-8(17),12-diene (2; 7:3 mixture of E and Z isomers), syn addition leading to 7 (58percent) was predominant.Smaller amounts of 8 (20percent) by syn addition to (E)-2 or anti addition to (Z)-2, 9 (5percent), 10 (2,5percent), and 11(1.5percent) were also formed. (E)-Labda-8(17),13-diene ((E)-3) gave 29percent 12 and 40percent 13 by syn addition, whereas (Z)-3 gave 57percent 12 by syn addition and 19percent 13 by anti addition.In trans-biformene (5) syn attack at C-12 to give 15 (27percent), 16 (10percent), 18 (12percent), and 19 (4percent) was greatly preferred to syn attack at C-13 to give 17 (6percent).In cis-biformene (6) syn attack at C-13 to give 17 (39percent) predominated slightly over anti attack at C-12 to give 15 (13percent), 16 (8percent), 18 (4percent), and 19 (4percent).Diels-Alder reactions with singlet oxygen leading to epidioxides 20 and 21 were relatively unimportant (7percent from 5, 5percent from 6).The epidioxides were converted to the naturally occurring furanolabdane pumiloxide (22).
